A phase I clinical study of Nimorazole as a hypoxic radiosensitizer. [electronic resource]
- International journal of radiation oncology, biology, physics Sep 1984
- 1765-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0360-3016
10.1016/0360-3016(84)90545-5 doi
Adult Aged Dose-Response Relationship, Drug Drug Evaluation Female Humans Male Middle Aged Neoplasms--metabolism Nimorazole--blood Nitroimidazoles--metabolism Radiation-Sensitizing Agents--blood Time Factors